Teleflex Incorporated chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 59.51
Dividend & Yield1.36$ (0.58%)
Beta 0.99
Market capitalization 11.23B
Operating cash flow 343.61M
ESG Scores 29.6

Company description

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Sector: Healthcare - Industry: Medical Instruments & Supplies

Financial Ratios
Quick Ratio1.4
Working Capital0.65
Return On Equity0.13
Debt To Equity0.46
Fixed Asset Ratio0.37
Fixed Interest Cover10.01

Financial data

Financial Statements

Cashflow Statement 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Change To Liabilities 36.02M 646k 94.02M -24.79M
Total Cashflows From Investing Activities -73.48M -837.78M 156.74M -259.41M
Net Borrowings -253.5M 575M -634.5M -140.25M
Total Cash From Financing Activities -418.84M 455.16M -715.82M -217.51M
Change To Operating Activities -31.02M -4.32M -28.41M 13.42M
Issuance Of Stock 21.21M 18.99M 23.55M
Net Income 461.47M 335.32M 485.37M 363.14M
Change In Cash -56.08M 74.8M 69.2M -153.05M
Effect Of Exchange Rate -3.29M 21.01M -23.13M -19.74M
Total Cash From Operating Activities 439.52M 436.41M 651.42M 343.61M
Depreciation 214.06M 227.25M 237.36M 230.59M
Change To Account Receivables -59.79M 44.75M -600k -38.46M
Other Cashflows From Financing Activities -123.71M -75.61M -41.22M -9.16M
Change To Netincome -125.81M -152.88M -203.16M -14.21M
Capital Expenditures -102.69M -90.69M -71.62M -79.19M

Income Statement 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Research Development 113.86M 119.75M 130.84M 153.82M
Income Before Tax 339.9M 357.73M 559.47M 445.92M
Net Income 461.47M 335.32M 485.37M 363.14M
Selling General Administrative 797.85M 781.73M 851.61M 861.4M
Gross Profit 1.41B 1.32B 1.55B 1.55B
Ebit 497.3M 423.39M 570.45M 534.87M
Operating Income 497.3M 423.39M 570.45M 534.87M
Interest Expense -80.27M -66.49M -56.97M -54.26M
Income Tax Expense -122.08M 21.93M 74.35M 83M
Total Revenue 2.6B 2.54B 2.81B 2.79B
Cost Of Revenue 1.19B 1.21B 1.26B 1.24B
Total Other Income ExpenseNet -157.39M -65.66M -10.98M -88.95M
Net Income From Continuing Ops 461.98M 335.8M 485.12M 362.92M
Net Income Applicable To Common Shares 461.47M 335.32M 485.37M 363.14M

Balance Sheet Statement 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Total Liabilities 3.33B 3.82B 3.12B 2.91B
Total Stockholder Equity 2.98B 3.34B 3.75B 4.02B
Other Current Liabilities 168.43M 50.48M 119.65M 71.66M
Total Assets 6.31B 7.15B 6.87B 6.93B
Common Stock 47.54M 47.81M 47.93M 47.96M
Other Current Assets 1.85M 1.75M 2.01M 3.19M
Retained Earnings 2.82B 3.1B 3.52B 3.82B
Treasury Stock -510.11M -459.89M -504.23M -558.41M
Cash 301.08M 375.88M 445.08M 292.03M
Total Current Liabilities 563.05M 540.03M 680.12M 581.49M
Other Stockholder Equity -344.39M -297.3M -346.96M -403.52M
Property, Plant, and Equipment 543.88M 574.55M 573.41M 578.42M
Total Current Assets 1.31B 1.42B 1.43B 1.41B
Net Tangible Assets -1.42B -1.77B -1.04B -820.93M
Net Receivables 418.67M 395.07M 383.57M 408.83M
Accounts Payable 102.92M 102.52M 118.24M 126.81M


Insider Transactions

Here are the insider transactions of stock shares related to Teleflex Incorporated:

Filer Name Transaction Text Ownership Date Filer Relation Shares
POWELL THOMAS EStock Award(Grant) at price 0.00 per share.D2023-02-28Chief Financial Officer2.36k
KELLY LIAM JStock Award(Grant) at price 0.00 per share.D2023-02-28Chief Executive Officer5.05k
HICKS CAMERON PStock Award(Grant) at price 0.00 per share.D2023-02-28Officer906
DEREN JOHNStock Award(Grant) at price 0.00 per share.D2023-02-28Officer414
WINTERS JAMESStock Award(Grant) at price 0.00 per share.D2023-02-28Officer912
LOGUE DANIEL V.Stock Award(Grant) at price 0.00 per share.D2023-02-28General Counsel1.14k
WHITE JAYStock Award(Grant) at price 0.00 per share.D2023-02-28Officer1.35k
KLASKO STEPHEN KConversion of Exercise of derivative security at price 78.50 per share.D2023-01-27Director3.01k
KELLY LIAM JConversion of Exercise of derivative security at price 78.62 - 82.26 per share.D2023-01-11Chief Executive Officer9.62k
KELLY LIAM JConversion of Exercise of derivative security at price 78.62 - 82.26 per share.D2023-01-11Chief Executive Officer9.62k
KELLY LIAM JSale at price 250.03 - 251.00 per share.D2022-12-30Chief Executive Officer16.34k
KELLY LIAM JConversion of Exercise of derivative security at price 78.62 per share.D2022-12-30Chief Executive Officer16.34k
RANDLE STUART ASale at price 283.31 per share.D2022-06-07Director3.01k
RANDLE STUART AConversion of Exercise of derivative security at price 78.50 per share.D2022-06-07Director3.01k
KELLY LIAM JStock Gift at price 0.00 per share.D2022-05-24Chief Executive Officer13.53k
HEINMILLER JOHN CStock Award(Grant) at price 0.00 per share.D2022-05-03Director399
HAGGERTY GRETCHEN RStock Award(Grant) at price 0.00 per share.D2022-05-03Director399
BABICH GEORGE JR.Stock Award(Grant) at price 0.00 per share.D2022-05-03Director520
RANDLE STUART AStock Award(Grant) at price 0.00 per share.D2022-05-03Director399
KRAKAUER ANDREW AStock Award(Grant) at price 0.00 per share.D2022-05-03Director399
KLASKO STEPHEN KStock Award(Grant) at price 0.00 per share.D2022-05-03Director399
DUNCAN CANDACE HStock Award(Grant) at price 0.00 per share.D2022-05-03Director399
PATIL NEENA MStock Award(Grant) at price 0.00 per share.D2022-05-03Director399
POWELL THOMAS EStock Award(Grant) at price 0.00 per share.D2022-03-01Chief Financial Officer1.74k
KELLY LIAM JStock Award(Grant) at price 0.00 per share.D2022-03-01Chief Executive Officer4.8k
HICKS CAMERON PStock Award(Grant) at price 0.00 per share.D2022-03-01Officer605
DEREN JOHNStock Award(Grant) at price 0.00 per share.D2022-03-01Officer301
WINTERS JAMESStock Award(Grant) at price 0.00 per share.D2022-03-01Officer635
LOGUE DANIEL V.Stock Award(Grant) at price 0.00 per share.D2022-03-01General Counsel558
WHITE JAYStock Award(Grant) at price 0.00 per share.D2022-03-01Officer997
KELLY LIAM JSale at price 330.00 per share.D2021-12-27Chief Executive Officer8.99k
KELLY LIAM JConversion of Exercise of derivative security at price 59.75 - 59.96 per share.D2021-12-27Chief Executive Officer8.99k
KRAKAUER ANDREW APurchase at price 307.00 - 307.46 per share.D2021-11-30Director1k
HICKS CAMERON PSale at price 350.00 per share.D2021-11-10Officer3.6k
HICKS CAMERON PConversion of Exercise of derivative security at price 121.00 per share.D2021-11-10Officer3.6k
HICKS CAMERON PStock Gift at price 0.00 per share.D2021-09-10Officer765
DEREN JOHNStock Award(Grant) at price 0.00 per share.D2021-08-24Officer45
KELLY LIAM JSale at price 374.85 - 378.92 per share.D2021-08-18Chief Executive Officer8.99k
KELLY LIAM JConversion of Exercise of derivative security at price 59.75 per share.D2021-08-18Chief Executive Officer8.99k
KLASKO STEPHEN KSale at price 422.00 - 423.95 per share.D2021-07-12Director3.56k
KLASKO STEPHEN KConversion of Exercise of derivative security at price 59.75 per share.D2021-07-12Director3.56k
HICKS CAMERON PSale at price 395.05 - 397.21 per share.D2021-06-10Officer3.48k
HICKS CAMERON PConversion of Exercise of derivative security at price 101.12 - 121.00 per share.D2021-06-10Officer3.48k
RANDLE STUART AStock Gift at price 395.80 per share.D2021-06-04Director278
RANDLE STUART ASale at price 395.66 per share.D2021-06-04Director2.38k
RANDLE STUART AConversion of Exercise of derivative security at price 59.75 per share.D2021-06-04Director3.56k
HEINMILLER JOHN CStock Award(Grant) at price 0.00 per share.D2021-05-04Director300
HAGGERTY GRETCHEN RStock Award(Grant) at price 0.00 per share.D2021-05-04Director300
PACKER RICHARD AStock Award(Grant) at price 0.00 per share.D2021-05-04Director300
BABICH GEORGE JR.Stock Award(Grant) at price 0.00 per share.D2021-05-04Director395
RANDLE STUART AStock Award(Grant) at price 0.00 per share.D2021-05-04Director300

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Teleflex Incorporated. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Teleflex Incorporated

Here is the result of two systematic investment strategies applied to Teleflex Incorporated. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Teleflex Incorporated

The following chart shows the equity curve of the two systematic investment strategies applied to Teleflex Incorporated:

Teleflex Incorporated automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 13.47% on the backtest period.

Performance at glance

Performance

13.47 %

Latent gain

414.69 $

Invested capital

3078.12 $

Annualized return

3.25 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Teleflex Incorporated

This is the result of two momentum investment strategies applied to Teleflex Incorporated. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Teleflex Incorporated

The following chart shows all the entries opened by the momentum investment system on Teleflex Incorporated:

Teleflex Incorporated momentum entries
  • The first momentum investment strategy would give 24.74% of return on Teleflex Incorporated. That represents 2078.09$ of latent gain with 8400.34$ of employed capital.
  • The second momentum investment strategy would give 27.08% of return on Teleflex Incorporated. That represents 1323.11$ of latent gain with 4886.33$ of employed capital.
Performance at glance (1Q Momentum)

Performance

24.74 %

Latent gain

2078.09 $

Invested capital

8400.34 $

Annualized return

0.2 %
Performance at glance (2Q Momentum)

Performance

27.08 %

Latent gain

1323.11 $

Invested capital

4886.33 $

Annualized return

7.4 %

Momentum equity curve on Teleflex Incorporated

The following chart shows the equity curve of the two momentum strategies applied to Teleflex Incorporated:

Teleflex Incorporated momentum equity

Note: the dividends potentially given by Teleflex Incorporated are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Teleflex Incorporated

The following chart shows the employed capital evolution of the two momentum strategies on Teleflex Incorporated since the beginning:

Teleflex Incorporated

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Teleflex Incorporated

Buy the dip entry openings on Teleflex Incorporated

Teleflex Incorporated

The performance achieved by the robo-advisor on Teleflex Incorporated is 0.43%. That represents 1.65$ of latent gain with 386.44$ of employed capital. The following chart shows Teleflex Incorporated stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Teleflex Incorporated, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0.43 %

Latent gain

1.65 $

Invested capital

386.44 $

Annualized return

0.2 %

Equity curve of the strategy applied to Teleflex Incorporated

The following chart shows the result of the investment strategy applied to Teleflex Incorporated:

Teleflex Incorporated

Note: the dividends potentially given by Teleflex Incorporated are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Teleflex Incorporated

The following chart shows the employed capital evolution since the beginning of the investment strategy on Teleflex Incorporated:

Teleflex Incorporated

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Teleflex Incorporated

In this section, I will compare the three previous investment strategies applied to Teleflex Incorporated.

Equity curve comparison on Teleflex Incorporated

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Teleflex Incorporated investment strategy comparison

Employed capital comparison on Teleflex Incorporated

Teleflex Incorporated investment comparison

Performance comparison on Teleflex Incorporated

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 13.47% 414.69$ 3078.12$ 3.25%
Momentum 1 quarter 24.74% 2078.09$ 8400.34$ 6.34%
Momentum 2 quarters 27.08% 1323.11$ 4886.33$ 7.4%
Non-directional 0.43% 1.65$ 386.44$ 0.2%
Annualized return comparison

Automatic investment

3.25 %

Momentum 1Q

7.4 %

Momentum 2Q

7.4 %

Non-directional

0.2 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Teleflex Incorporated:


Company information

Company name Teleflex Incorporated
Country United States
City Wayne
Address 550 East Swedesford Road
Phone 610 225 6800
Website www.teleflex.com
FullTime employees 15500
Industry Medical Instruments & Supplies
Sector Healthcare
Exchange XNYS
Ticker TFX
Market www.nyse.com

Teleflex Incorporated ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 4.8
Peer Environment Performance 2.6416666666667
Environment Percentile unknown
Palm Oil no
Nuclear no
Fur Leather no
GMO no
Coal no
Pesticides no
Animal Testing yes

Social scores

Social ESG Factors Scores
Social Score 16.1
Peer Social Performance 12.131111111111
Social Percentile unknown
Highest Controversy 2
Peer Highest Controversy Performance 1.6486486486486
Adult no
Gambling no
Alcoholic no
Tobacco no
Catholic no
Controversial Weapons no
Small Arms no
Military Contract no
Peer Count yes

Related Controversy: Customer IncidentsBusiness Ethics Incidents


Governance scores

Governance ESG Factors Scores
Governance Score 8.7
Peer Governance Performance 7.7769444444444
Governance Percentile unknown

ESG at glance
Total ESG Scores: 29.6
Environment Score: 4.8
Social Score: 16.1
Governance Score: 8.7

ESG Performance: AVG_PERF

Peer Group: Healthcare

Peer Esg Score Performance: 22.573513513514

Rating Year: 2023

Rating Month: 1

Max Age: 86400

Percentile: 64